AVITA Medical (RCEL) Capital Expenditures (QoQ) (2019 - 2025)
AVITA Medical (RCEL) Capital Expenditures (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn |
| 10 | AVITA Medical | 134.29 Mn | 117.95 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -54.89% |
| Sep 30, 2025 | 221.92% |
| Jun 30, 2025 | -66.97% |
| Mar 31, 2025 | 175.68% |
| Dec 31, 2024 | -549.23% |
| Sep 30, 2024 | 108.07% |
| Jun 30, 2024 | -170.18% |
| Mar 31, 2024 | 287.50% |
| Dec 31, 2023 | -41.04% |
| Sep 30, 2023 | -13.89% |
| Jun 30, 2023 | 6,477,577.78% |
| Mar 31, 2023 | 100.00% |
| Sep 30, 2021 | 3,715.00% |
| Jun 30, 2021 | -96.21% |
| Mar 31, 2021 | 1,010.34% |
| Dec 31, 2020 | -127.75% |
| Mar 31, 2020 | 97.22% |
| Dec 31, 2019 | -1,100.00% |